Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03687502 · ClinicalTrials.gov registry record · Phase 2
The Role of Contrast Enhanced Ultrasound in Appendicitis
A Phase 2 study of Acute Appendicitis, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- Phase 2
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT03687502: Completed Phase 2 study of Acute Appendicitis, sponsored by Children's Mercy Hospital Kansas City.
NCT03687502 is a Phase 2 study of Acute Appendicitis that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 37 participants, below the 884-participant average among 4 other Acute Appendicitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03687502, a Phase 2 study of Acute Appendicitis, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
This study seeks to determine the efficacy of Contrast Enhanced Ultrasound (CEUS) in improving the diagnosis of acute appendicitis in children, when compared to the standard grey-scale ultrasound.
Primary Outcome
Number of children with an accurate diagnosis of appendicitis when compared to the standard grey scale ultrasound and/ or CT scan based on the following categories: Category 1: Normal appendix Category 2: Appendix not fully visualized without secondary signs Category 3: Appendix not fully visualized with secondary signs Category 4: Appendicitis
Conditions Studied
Interventions
- DRUG Sulfur hexafluoride lipid-type A microspheres
Study Locations (1)
Missouri
- Children's Mercy Kansas City - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2022-07-05 |
| Phase | Phase 2 |
What the finished NCT03687502 record still lists
NCT03687502 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 884-participant average among 4 other Acute Appendicitis trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Acute Appendicitis appearing as the primary indexed condition, and to 1 intervention - of which Sulfur hexafluoride lipid-type A microspheres is the first listed.
NCT03687502 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03687502 about?
NCT03687502 is a clinical study titled "The Role of Contrast Enhanced Ultrasound in Appendicitis". This study seeks to determine the efficacy of Contrast Enhanced Ultrasound (CEUS) in improving the diagnosis of acute appendicitis in children, when compared to the standard grey-scale ultrasound.
What is the current status of trial NCT03687502?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2019-01-04. Estimated completion is 2022-07-05.
What conditions does trial NCT03687502 study?
This clinical trial studies the following conditions: Acute Appendicitis.
What interventions are being tested in trial NCT03687502?
The interventions under investigation include: Sulfur hexafluoride lipid-type A microspheres (DRUG).
Who is sponsoring clinical trial NCT03687502?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03687502 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Appendicitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Retrospective Acute Care Appendectomy Study
RECRUITING
-
Initial Antibiotics and Delayed Appendectomy for Acute Appendicitis
COMPLETED · NA
-
The Performance of the APPY1 Test in the Evaluation of Possible Acute Appendicitis
COMPLETED
-
Point of Care Ultrasound for Evaluation of Suspected Appendicitis in the Emergency Department
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02800486 · 37 participants · Phase 2
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
- NCT03173937 · 37 participants · Phase 1
Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome
- NCT03295227 · 37 participants · Phase 1
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer
- NCT03401047 · 37 participants · Early Phase 1
Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI